BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
NGD Infection Prevention was formed to scale the delivery of sequence-based transmission detection
Nona aims to help global biopharmaceutical companies fast-track clinical trial initiation without compromising scientific rigor or quality standards
The initiative is focused on a problem that continues to plague cancer outcomes in India
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
Angelini Ventures has already invested €125 million in 22 startups
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
Subscribe To Our Newsletter & Stay Updated
